Crenolanib

SI-6940

Crenolanib, >98% (HPLC)

CAS No. : [670220-88-9]

Synonyms : CP-868596

IUPAC Name : 1-(2-(5-((3-Methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Crenolanib selectively inhibits wild‑type and mutant FLT3 and PDGFRα/β with high affinity, displaying Kd values of 0.74 nM for FLT3 and 2.1/3.2 nM for PDGFRα/β. Its potency makes it a valuable tool for studying FLT3‑ and PDGFR‑driven signaling pathways.

References : Heinrich M. C. et al.: Clin. Cancer Res., 18(16), 4375-84, 2012; Mathias T. J. et al.: Invest. New Drugs, 33(2), 300-309, 2015; Wang P. et al.: Onco. Targets Ther., 7, 1761-8, 2014.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.